Amarantus Bioscience Holdings Inc (AMBS)

[betelgeuse]

http://neuroscene.com/?p=111

Some posters questioned why Big Pharma have not scooped up AMBS already? Here is your answer: The audio explains why GDNF for PD failed (inspite of being extremely potent), at 09:25 minutes. And discusses Alzheimer's at 10:30 minutes.

This is where MANF-CED partnership will be a game-changer. We already know that MANF is better than the extremely-potent-GDNF. If successful (my experience says it will be), AMBS will be a page-1 headline on every newspaper, magazine and news channel. I see AMBS MANF PD programme getting a $2B+ funding from Big Pharma, in a year or so. There is a reason why Dr. Rubinfeld decided to be an advisor to a virtually unknown (yet) AMBS.

Forget about "AMBS the company". Concentrate on "AMBS the research organization". And remember that great things come in small packages.